Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis

BACKGROUND: Atherosclerosis is a major cardiovascular disease that causes ischemia of the heart, brain, or extremities, and can lead to infarction. The hypolipidemic agent atorvastatin calcium (Ato) alleviates atherosclerosis by reducing plasma lipid and inflammatory factors. However, the low bioava...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoxia, Xiao, Hong, Lin, Chaowen, Sun, Weitong, Wu, Teng, Wang, Jin, Chen, Bin, Chen, Xia, Cheng, Du
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339643/
https://www.ncbi.nlm.nih.gov/pubmed/30697048
http://dx.doi.org/10.2147/IJN.S189819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339643/
https://www.ncbi.nlm.nih.gov/pubmed/30697048
http://dx.doi.org/10.2147/IJN.S189819

Ejemplares similares